198 related articles for article (PubMed ID: 16049809)
1. Modeling the dissemination of mammography in the United States.
Cronin KA; Yu B; Krapcho M; Miglioretti DL; Fay MP; Izmirlian G; Ballard-Barbash R; Geller BM; Feuer EJ
Cancer Causes Control; 2005 Aug; 16(6):701-12. PubMed ID: 16049809
[TBL] [Abstract][Full Text] [Related]
2. Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach.
Berry DA; Inoue L; Shen Y; Venier J; Cohen D; Bondy M; Theriault R; Munsell MF
J Natl Cancer Inst Monogr; 2006; (36):30-6. PubMed ID: 17032892
[TBL] [Abstract][Full Text] [Related]
3. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
4. Geographic association between mammography use and mortality reduction in the US.
Das B; Feuer EJ; Mariotto A
Cancer Causes Control; 2005 Aug; 16(6):691-9. PubMed ID: 16049808
[TBL] [Abstract][Full Text] [Related]
5. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the impact of breast cancer screening in South Australia.
Tallis GM; O'Neill TJ
Intern Med J; 2009 Mar; 39(3):174-8. PubMed ID: 19383066
[TBL] [Abstract][Full Text] [Related]
7. Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the cisnet breast cancer base case analysis.
Cronin KA; Feuer EJ; Clarke LD; Plevritis SK
J Natl Cancer Inst Monogr; 2006; (36):112-21. PubMed ID: 17032901
[TBL] [Abstract][Full Text] [Related]
8. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
Jemal A; Ward E; Thun MJ
Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
[TBL] [Abstract][Full Text] [Related]
9. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
[TBL] [Abstract][Full Text] [Related]
10. Mammography surveillance and mortality in older breast cancer survivors.
Lash TL; Fox MP; Buist DS; Wei F; Field TS; Frost FJ; Geiger AM; Quinn VP; Yood MU; Silliman RA
J Clin Oncol; 2007 Jul; 25(21):3001-6. PubMed ID: 17548838
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
12. Reliability and validity of Champion's Health Belief Model Scale for breast cancer screening among Malaysian women.
Parsa P; Kandiah M; Mohd Nasir MT; Hejar AR; Nor Afiah MZ
Singapore Med J; 2008 Nov; 49(11):897-903. PubMed ID: 19037556
[TBL] [Abstract][Full Text] [Related]
13. Physician and patient characteristics associated with outpatient breast cancer screening recommendations in the United States: analysis of the National Ambulatory Medical Care Survey Data 1996-2004.
Bhosle M; Samuel S; Vosuri V; Paskett E; Balkrishnan R
Breast Cancer Res Treat; 2007 May; 103(1):53-9. PubMed ID: 17028978
[TBL] [Abstract][Full Text] [Related]
14. Service screening mammography reduces breast cancer mortality among elderly women in Turku.
Parvinen I; Helenius H; Pylkkänen L; Anttila A; Immonen-Räihä P; Kauhava L; Räsänen O; Klemi PJ
J Med Screen; 2006; 13(1):34-40. PubMed ID: 16569304
[TBL] [Abstract][Full Text] [Related]
15. Scheduling mammography screening for the early detection of breast cancer in Korean women.
Lee SY; Jeong SH; Kim J; Jung SH; Song KB; Nam CM
J Med Screen; 2007; 14(4):205-9. PubMed ID: 18078566
[TBL] [Abstract][Full Text] [Related]
16. A stochastic simulation model of U.S. breast cancer mortality trends from 1975 to 2000.
Plevritis SK; Sigal BM; Salzman P; Rosenberg J; Glynn P
J Natl Cancer Inst Monogr; 2006; (36):86-95. PubMed ID: 17032898
[TBL] [Abstract][Full Text] [Related]
17. The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods.
Mandelblatt J; Schechter CB; Lawrence W; Yi B; Cullen J
J Natl Cancer Inst Monogr; 2006; (36):47-55. PubMed ID: 17032894
[TBL] [Abstract][Full Text] [Related]
18. The MISCAN-Fadia continuous tumor growth model for breast cancer.
Tan SY; van Oortmarssen GJ; de Koning HJ; Boer R; Habbema JD
J Natl Cancer Inst Monogr; 2006; (36):56-65. PubMed ID: 17032895
[TBL] [Abstract][Full Text] [Related]
19. Evolution of breast cancer screening in countries with intermediate and increasing incidence of breast cancer.
Wu GH; Chen LS; Chang KJ; Hou MF; Chen SC; Liu TJ; Huang CS; Hsu GC; Yu CC; Jeng LL; Chen ST; Chou YH; Wu CY; Shin-Lan K; Chen TH;
J Med Screen; 2006; 13 Suppl 1():S23-7. PubMed ID: 17227638
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cancer registry and clinical data as predictors for breast cancer survival.
Seppänen J; Heinävaara S; Holli K; Hakulinen T
Cancer Causes Control; 2008 Dec; 19(10):1299-304. PubMed ID: 18752035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
